• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature Estimating the Effects of Non-Pharmaceutical Interventions on COVID-19 in Europe

tetano

Editor, Senior Moderator
Nature


. 2020 Jun 8.
doi: 10.1038/s41586-020-2405-7. Online ahead of print.
Estimating the Effects of Non-Pharmaceutical Interventions on COVID-19 in Europe


Seth Flaxman[SUP] 1 [/SUP], Swapnil Mishra[SUP] 2 [/SUP], Axel Gandy[SUP] 1 [/SUP], H Juliette T Unwin[SUP] 2 [/SUP], Thomas A Mellan[SUP] 2 [/SUP], Helen Coupland[SUP] 2 [/SUP], Charles Whittaker[SUP] 2 [/SUP], Harrison Zhu[SUP] 1 [/SUP], Tresnia Berah[SUP] 1 [/SUP], Jeffrey W Eaton[SUP] 2 [/SUP], M?lodie Monod[SUP] 1 [/SUP], Imperial College COVID-19 Response Team; Azra C Ghani[SUP] 2 [/SUP], Christl A Donnelly[SUP] 2 3 [/SUP], Steven M Riley[SUP] 2 [/SUP], Michaela A C Vollmer[SUP] 2 [/SUP], Neil M Ferguson[SUP] 2 [/SUP], Lucy C Okell[SUP] 2 [/SUP], Samir Bhatt[SUP] 4 [/SUP]



Collaborators, Affiliations

Abstract

Following the emergence of a novel coronavirus[SUP]1[/SUP] (SARS-CoV-2) and its spread outside of China, Europe has experienced large epidemics. In response, many European countries have implemented unprecedented non-pharmaceutical interventions such as closure of schools and national lockdowns. We study the impact of major interventions across 11 European countries for the period from the start of COVID-19 until the 4[SUP]th[/SUP] of May 2020 when lockdowns started to be lifted. Our model calculates backwards from observed deaths to estimate transmission that occurred several weeks prior, allowing for the time lag between infection and death. We use partial pooling of information between countries with both individual and shared effects on the reproduction number. Pooling allows more information to be used, helps overcome data idiosyncrasies, and enables more timely estimates. Our model relies on fixed estimates of some epidemiological parameters such as the infection fatality rate, does not include importation or subnational variation and assumes that changes in the reproduction number are an immediate response to interventions rather than gradual changes in behavior. Amidst the ongoing pandemic, we rely on death data that is incomplete, with systematic biases in reporting, and subject to future consolidation. We estimate that, for all the countries we consider, current interventions have been sufficient to drive the reproduction number [Formula: see text] below 1 (probability [Formula: see text]< 1.0 is 99.9%) and achieve epidemic control. We estimate that, across all 11 countries, between 12 and 15 million individuals have been infected with SARS-CoV-2 up to 4[SUP]th[/SUP] May, representing between 3.2% and 4.0% of the population. Our results show that major non-pharmaceutical interventions and lockdown in particular have had a large effect on reducing transmission. Continued intervention should be considered to keep transmission of SARS-CoV-2 under control.
 
Back
Top Bottom